Netweb Technologies India Limited CRISIL Upgrades Long-Term Rating to ‘Crisil A+/Stable’

Netweb Technologies India Limited has announced an upgrade in its long-term credit rating by CRISIL Ratings to ‘Crisil A+/Stable’ from ‘Crisil A/Stable’. The company’s short-term rating has been reaffirmed at ‘Crisil A1′. This upgrade reflects a sustained improvement in Netweb Technologies’ business risk profile, driven by healthy scalability and robust revenue growth. The total bank loan facilities rated have also been enhanced to Rs. 700 Crore.

Netweb Technologies Receives Credit Rating Upgrade

Netweb Technologies India Limited (NTIL) has been notified of a significant credit rating upgrade by CRISIL Ratings Limited. The long-term rating for the company’s bank loan facilities has been upgraded to ‘Crisil A+/Stable’, an improvement from the previous ‘Crisil A/Stable’ rating. Concurrently, the short-term rating has been reaffirmed at ‘Crisil A1’. The total value of bank loan facilities rated by CRISIL has been enhanced from Rs. 260 Crore to Rs. 700 Crore.

Rationale for the Upgrade

The rating upgrade is attributed to a sustained improvement in NTIL’s business risk profile. This enhancement is driven by the company’s healthy scalability and a range-bound operating profitability. NTIL has demonstrated consistent growth, marked by regular additions of new customers and diversification in product and service offerings, particularly in GPU-based artificial intelligence (AI) infrastructure. This has resulted in a compound annual growth rate (CAGR) of approximately 70% in revenue over the three fiscal years through 2026, with revenue projected to reach around Rs. 2,183 crore in fiscal 2026.

Furthermore, a substantial order book of Rs. 2,098 crore, coupled with L1 orders of Rs. 328 crore as of March 2026, provides strong revenue visibility for the medium term. While operating profitability has seen a moderation, from 15.8% in fiscal 2023 to an estimated 13.4% in fiscal 2026, this has been offset by robust revenue growth. NTIL’s ability to maintain operating profitability amidst sustained business growth will be a key monitorable going forward.

Financial Strength and Liquidity

The company’s financial risk profile and liquidity are considered strong, with a low dependence on external debt. Despite operations being working capital-intensive, the reliance on external debt has remained negligible, maintaining a total outside liabilities to tangible networth (TOLTNW) ratio of 2.1 times as of March 31, 2026. The absence of term debt repayments, healthy cushion in bank lines, and access to unencumbered cash further bolster liquidity. Liquidity is healthy, with a surplus of around Rs. 350-370 crore in cash, bank balance, and investments as of March 31, 2026. Expected cash accruals of Rs. 250-300 crore are anticipated to cover NIL annual term debt obligations over the medium term.

Key Strengths and Weaknesses

NTIL’s strengths include a strong market presence, supported by an experienced management team with deep expertise in high-performance computing (HPC), storage, and cloud business segments. Its established design architecture capabilities, driven by continuous R&D investment, and a healthy financial risk profile are also significant advantages. These are partially offset by working capital-intensive operations and exposure to high supplier and customer concentration risks, along with increasing competition.

The company’s networth increased to over Rs. 720.9 crore as of March 31, 2026. The financial flexibility is demonstrated by comfortable gearing and a robust interest coverage ratio, which stood at 22.3 times in fiscal 2026. The outlook for NTIL is stable, with CRISIL Ratings anticipating continued benefits from its promoter’s experience and established client relationships.

Key Financial Indicators

As on / for the period ended March 31 2026 2025
Operating income (Rs crore) 2183.6 1149.02
Reported profit after tax (PAT) (Rs crore) 205.8 113.6
PAT margin (%) 9.43 9.88
Adjusted debt/adjusted networth (Times) 0.38 0.0
Interest coverage (Times) 22.4 39.4

Source: BSE

Previous Article

Aarti Pharmalabs Limited Board Approves Audited Financial Results, Recommends Final Dividend

Next Article

Marksans Pharma Ltd. Investor Presentation for Q4FY26 and FY26 Highlights Key Growth and Financials